MedPath

D-Dimer Vs Serial Compression Ultrasound Study

Phase 3
Completed
Conditions
Deep Vein Thrombosis
Registration Number
NCT00182351
Lead Sponsor
Hamilton Health Sciences Corporation
Brief Summary

To determine whether d-dimer testing can be used to simplify and reduce the costs of the diagnostic approach to patients with clinically suspected deep vein thrombosis

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
810
Inclusion Criteria
  • first suspected deep vein thrombosis
  • no previous venous thromboembolism
  • referred to thromboembolism outpatient clinic
Exclusion Criteria
  • comorbid condition limiting survival to less than six months
  • contraindication to venography (contrast allergy, etc.)
  • receiving long term warfarin therapy
  • receiving full dose heparin therapy for more than 48 hours
  • absence of symptoms during the five days immediately prior to presentation
  • symptoms of pulmonary embolism
  • pregnancy
  • geographic inaccessibility which precludes follow-up

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
safety of withholding anticoagulants
Secondary Outcome Measures
NameTimeMethod
deep vein thrombosis
pulmonary embolism
death

Trial Locations

Locations (3)

Hamilton Health Sciences - Hamilton General Hospital

🇨🇦

Hamilton, Ontario, Canada

St. Joseph's Hospital

🇨🇦

Hamilton, Ontario, Canada

Hamilton Health Sciences - Henderson Hospital

🇨🇦

Hamilton, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath